RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:79345

Brachytelephalangic chondrodysplasia punctata

high confidenceDisorder

Publications

468

68.8th percentile

Trials

0

Interventional, condition-specific

Researchers

610

Distinct authors in sample

Gene link

ARSL

Definitive

Readiness

3/6

Stages with a signal

Clinical definition (Orphanet)

Brachytelephalangic chondrodysplasia punctata (BCDP) is a form of non-rhizomelic chondrodysplasia punctata, a primary bone , characterized by hypoplasia of the distal phalanges of the fingers, nasal hypoplasia, epiphyseal stippling appearing in the first year of life, as well as mild and non-rhizomelic shortness of the long bones.

How rare: How common this is has not been clearly measured.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (7)

ARSE X-linked chondrodysplasia punctata · X-linked chondrodysplasia punctata 1 · X-linked chondrodysplasia punctata caused by mutation in ARSE · X-linked chondrodysplasia punctata caused by mutation in arse · arse X-linked chondrodysplasia punctata · brachytelephalangic chondrodysplasia punctata · chondrodysplasia punctata, X-linked recessive, X-linked recessive

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

3/6 stages with a signal

No matched interventional trial; the gene is known and literature exists — preclinical or natural-history work may still be the practical next step.

  1. Gene identifiedPresent

    Definitive — ARSL

  2. LiteraturePresent

    468 matched papers (211 in last 10 years) Source

  3. Phenotype characterisedPresent

    70 HPO annotations (e.g. Cervical spinal canal stenosis; Cervical vertebral dysplasia; Stippling of the epiphyses of the distal phalanges of the hand) Source

  4. Animal modelNot found

    No Alliance genotype “model of” associations via Monarch for these Mondo IDs

  5. Orphan designationNot found

    No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source

  6. Interventional trialNot found

    No matched interventional trial under our ClinicalTrials.gov rules

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Yes — we know a specific gene responsible (ARSL).

GenCC classification: Definitive.

Phenotypes (Monarch / HPO)

70

Associated phenotypes · MONDO:0010555

  • Cervical spinal canal stenosis
  • Cervical vertebral dysplasia
  • Stippling of the epiphyses of the distal phalanges of the hand
  • Cervical spine instability
  • Abnormal hyoid bone morphology

Showing 5 of 70 — open Monarch for the full list.

Animal models (Monarch / Alliance)

None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.

Monarch fetch 2026-07-29

Therapies

Designations, candidates, and chemicals

FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.

Orphan designation (FDA · EMA)

No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.

Open Targets candidates

No drugs or clinical candidates returned for this Mondo ID on Open Targets.

CTD chemicals (MyDisease.info)

No CTD chemical associations returned for this Mondo ID.

Literature

Is anyone studying this?

468

468 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.

468 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).

211 in the last 10 years · high confidence · 68.8th percentile (publications denominator)

Phrase hits: 63 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

610

Distinct author names in 63 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Brunetti-Pierri N4 papers · 2018

    Telethon Institute of Genetics and Medicine, Pozzuoli, Italy; Department of Translational Medicine, Federico II University of Naples, Italy.

    Papers in Europe PMC
  2. 02
    Parenti G3 papers · 2018

    Telethon Institute of Genetics and Medicine, Pozzuoli, Italy; Department of Translational Medicine, Federico II University of Naples, Italy.

    Papers in Europe PMC
  3. 03
    Becker LC2 papers · 2023

    Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

    Papers in Europe PMC
  4. 04
    Boerwinkle E2 papers · 2023

    Human Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.

    Papers in Europe PMC
  5. 05
    Braverman N2 papers · 2013
    Papers in Europe PMC
  6. 06
    Garel C2 papers · 2009
    Papers in Europe PMC
  7. 07
    Guo X2 papers · 2023

    BGI-Wuhan Clinical Laboratory, BGI-Shenzhen, 430074, Wuhan, China.

    Papers in Europe PMC
  8. 08
    Gupta N2 papers · 2024

    Genetic Unit, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.

    Papers in Europe PMC
  9. 09
    Hall CM2 papers · 2015
    Papers in Europe PMC
  10. 10
    Herman TE2 papers · 2010

    St. Louis Children's Hospital Department of Radiology, 510 South Kingshighway Blvd., St. Louis, MO 63110, USA. hermant@mir.wustl.edu

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).

Data as of 11 September 2026 · last trial check 11 September 2026

No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.

high confidence · 38.6th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.

Other registries (secondary)

Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.

raw 0 · after dedupe 0 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 0 · dropped 0 · fetched 2026-07-30

Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri

No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).

Where to find support

Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.

Orphanet entry for Brachytelephalangic chondrodysplasia punctata — check Associations / patient organisations on that page.

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

("Brachytelephalangic chondrodysplasia punctata" OR "ARSE X-linked chondrodysplasia punctata" OR "X-linked chondrodysplasia punctata 1" OR "X-linked chondrodysplasia punctata caused by mutation in ARSE" OR "chondrodysplasia punctata, X-linked recessive, X-linked recessive") OR ("ARSL" OR "ARSL syndrome" OR "ARSL-related")

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Brachytelephalangic chondrodysplasia punctata" OR "ARSE X-linked chondrodysplasia punctata" OR "X-linked chondrodysplasia punctata 1" OR "X-linked chondrodysplasia punctata caused by mutation in ARSE" OR "chondrodysplasia punctata, X-linked recessive, X-linked recessive"

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus

Ingested 2026-07-27T02:19:36.812Z